Re:Pancreatic cancer halted by virus injection in three pati...
by mmahemoff on Thursday November 19, 2026 @11:23PM
(#50570144)
Arguably a breakthrough cure should trigger a revision of screening protocols, to be more vigilant with early tests and how the results are acted upon. On a cost-benefit analysis, the benefit side just went up while the cost (stress from false positives, time and money, unnecessary invasive procedures) remains the same. And, in an ideal world, should also lead to more resources on improving the screening tech.
[ Parent
| on HN ]
There are no comments on this comment yet.